DailyStocks Stock Article Search

855 Spam-Free Article(s) Found

Sort:

Date

Filter:

All

DeepLinks

Symbol	Name	Last Close	Mkt Cap	DailyStocks' Rating Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.	Vote Now! Thursday’s Close
BIOS	BioScrip, Inc.	$2.99	$382.86M	N/A	Up Down

Article Searches

http://feeds.benzinga.com/~r/benzinga/~3/JEFZN_e2hHI/mid-day-market-update-melinta-therapeutics-gains-after-fda-accepts-snda-for-bacterial-pneumonia-drug Jun 19, 2019 -

Midway through trading Wednesday, the Dow traded up 0.04% to 26476.32 while the NASDAQ fell 0.06% to 7948.95. The S&P also fell, dropping 0.03% to 2,917.02.

Leading and Lagging Sectors

https://seekingalpha.com/news/3472412-arcturus-therapeutics-myos-rens-technology-among-healthcare-gainers-sesen-bio-leads-losers?source=feed_news_all Jun 19, 2019 - Gainers: Melinta Therapeutics (NASDAQ:MLNT) +144%. Arcturus Therapeutics (NASDAQ:ARCT) +35%. MYOS RENS Technology (NASDAQ:MYOS) +23%. Enlivex Therapeutics (NASDAQ:ENLV) +11%. Concord Medical Services 0

http://feeds.benzinga.com/~r/benzinga/~3/YFWFqOEAeZk/the-daily-biotech-pulse-positive-readouts-from-adamas-and-ironwood-sesen-bio-to-offer-shares-stok Jun 19, 2019 -

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peaks

(Biotech stocks Hitting 52-week highs on June 18)

https://seekingalpha.com/article/4270958-provention-bio-may-offer-new-hope-people-type-1-diabetes-latest-clinical-data?source=feed_sector_healthcare Jun 19, 2019 - Provention Bio was able to show that those given PRV-031 were able to delay the onset of Type 1 Diabetes in a study known as At Risk.PRV-031 is also being explored in a phase 3 study to treat patients 0

https://www.chron.com/business/energy/article/LyondellBasell-Neste-produce-bio-plastics-14014259.php Jun 18, 2019 - 0

https://seekingalpha.com/news/3471996-unity-bio-reports-promising-ubx0101-data?source=feed_news_all Jun 18, 2019 - Unity Biotechnology (NASDAQ:UBX) has announced results from its first-in-human Phase 1 study of UBX0101 in patients with moderate to severe osteoarthritis (OA) of the knee. The study demonstr 0

http://feeds.benzinga.com/~r/benzinga/~3/orWYPFtx0m0/invitae-will-acquire-singular-bio-for-55m Jun 17, 2019 -

Invitae (NYSE: NVTA) will acquire Singular Bio for $55 million in a mostly stock deal.

https://www.fool.com/investing/2019/06/15/is-18-million-for-bluebird-bios-new-gene-therapy-r.aspx?source=iedfolrf0000001 Jun 15, 2019 - Following European approval earlier this month, bluebird bio announced its beta-thalassemia gene therapy will launch with a sky-high price tag. 0

https://seekingalpha.com/article/4270330-provention-bio-panacea-diabetes?source=feed_sector_healthcare Jun 14, 2019 - After decades of fairy tale wishes, we're now close to the reality of having a medicine that can simultaneously delay Type 1 diabetes on-set and prevent its occurrence.Provention Bio brought the sweet 0

https://seekingalpha.com/news/3471273-bio-techne-gets-ny-nod-prostate-test?source=feed_news_all Jun 13, 2019 - The New York Department of Health has issued a laboratory permit to Bio-Techne (NASDAQ:TECH) to provide its ExoDx Prostate Intelliscore test there.The company has performed over 25K tests since its 20 0

Pages: 12 3 4 5 6...86

Page 1>